Terms: = Breast cancer AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Treatment
5 results:
1. Long-term treatment results of conventional and hypofractionation radiotherapy in postmastectomy cancer breast patients: A retrospective study from rural cancer center of Maharashtra, India.
Jain VS; Bakshi N; Jain SM; Mandloi V; Malik Y; Kharde A
J Cancer Res Ther; 2024 Jan; 20(1):396-403. PubMed ID: 38554352
[TBL] [Abstract] [Full Text] [Related]
2. Microarray data analysis reveals gene expression changes in response to ionizing radiation in MCF7 human breast cancer cells.
Bai J; Luo Y; Zhang S
Hereditas; 2020 Sep; 157(1):37. PubMed ID: 32883354
[TBL] [Abstract] [Full Text] [Related]
3. lmo2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Parvin S; Ramirez-Labrada A; Aumann S; Lu X; Weich N; Santiago G; Cortizas EM; Sharabi E; Zhang Y; Sanchez-Garcia I; Gentles AJ; Roberts E; Bilbao-Cortes D; Vega F; Chapman JR; Verdun RE; Lossos IS
Cancer Cell; 2019 Sep; 36(3):237-249.e6. PubMed ID: 31447348
[TBL] [Abstract] [Full Text] [Related]
4. lmo2 Enhances Lamellipodia/Filopodia Formation in Basal-Type breast cancer Cells by Mediating ARP3-Profilin1 Interaction.
Liu Y; Wu C; Zhu T; Sun W
Med Sci Monit; 2017 Feb; 23():695-703. PubMed ID: 28170369
[TBL] [Abstract] [Full Text] [Related]
5. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.
Yong T; Sun A; Henry MD; Meyers S; Davis JN
J Cell Biochem; 2011 Sep; 112(9):2340-51. PubMed ID: 21520243
[TBL] [Abstract] [Full Text] [Related]